series-a
Stage
2018
Founded
2
Investors
About
TenSixty Bio is developing novel cancer therapies by integrating biology, machine learning, and high-throughput technologies to discover precise antibody targets and create more effective drugs.
Explore TenSixty Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.